|
|
Volumn 22, Issue 8, 2004, Pages 495-498
|
|
Pharmacogenomics and the evolution of healthcare: Is it time for cost-effectiveness analysis at the individual level?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SAFETY;
GENETIC HETEROGENEITY;
GENETIC VARIABILITY;
HEADACHE;
HEALTH BEHAVIOR;
HEALTH CARE;
HEALTH CARE COST;
HUMAN;
MANAGED CARE ORGANIZATION;
MEDICAL DECISION MAKING;
NAUSEA;
PATIENT ATTITUDE;
PHARMACOGENOMICS;
PHYSICIAN;
PRIORITY JOURNAL;
REVIEW;
SOCIAL WELFARE;
TOXICITY;
TREATMENT OUTCOME;
VISUAL ANALOG SCALE;
GENETICS AND REPRODUCTION;
HEALTH CARE AND PUBLIC HEALTH;
COST-BENEFIT ANALYSIS;
DELIVERY OF HEALTH CARE;
DRUG THERAPY;
GENETIC HETEROGENEITY;
HUMANS;
PHARMACOGENETICS;
QUALITY-ADJUSTED LIFE YEARS;
|
|
EID: 3042781689
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200422080-00002 Document Type: Review |
|
Times cited : (16)
|
|
References (5)
|
